Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiac effects of losartan in hypertrophic cardiomyopathy
2011-001191-19Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of losartan in hypertrophic cardiomyopathy (HCM) and Hypertrophic Obstructive Cardiomyopathy (HOCM), sponsored by Rigshospitalet. Primary endpoint: Left ventricular mass. Started Sep 2011; status: completed.
02
Drugs
losartan
03
Conditions
hypertrophic cardiomyopathy (HCM)Hypertrophic Obstructive Cardiomyopathy (HOCM)
Beyond the preview
Go deeper on 2011-001191-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001191-19.